Interpace Biosciences, Inc. (IDXG)
1.43
-0.09
(-6.09%)
USD |
OTCM |
Aug 24, 16:00
Interpace Biosciences Net Income (Quarterly) : 0.266M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.266M |
| March 31, 2026 | 0.831M |
| December 31, 2025 | 22.75M |
| September 30, 2025 | 1.011M |
| June 30, 2025 | -0.533M |
| March 31, 2025 | 1.754M |
| December 31, 2024 | 1.865M |
| September 30, 2024 | 1.758M |
| June 30, 2024 | 2.511M |
| March 31, 2024 | 0.812M |
| December 31, 2023 | 0.992M |
| September 30, 2023 | -0.528M |
| June 30, 2023 | 0.395M |
| March 31, 2023 | 0.43M |
| December 31, 2022 | -1.407M |
| September 30, 2022 | -1.254M |
| June 30, 2022 | -3.887M |
| March 31, 2022 | -2.193M |
| December 31, 2021 | -1.742M |
| September 30, 2021 | -1.319M |
| June 30, 2021 | -3.388M |
| March 31, 2021 | -4.153M |
| December 31, 2020 | -8.087M |
| September 30, 2020 | -6.169M |
| June 30, 2020 | -5.514M |
| Date | Value |
|---|---|
| March 31, 2020 | -6.429M |
| December 31, 2019 | -10.70M |
| September 30, 2019 | -7.388M |
| June 30, 2019 | -5.369M |
| March 31, 2019 | -3.362M |
| December 31, 2018 | -4.183M |
| September 30, 2018 | -3.008M |
| June 30, 2018 | -1.873M |
| March 31, 2018 | -3.143M |
| December 31, 2017 | -4.956M |
| September 30, 2017 | -3.387M |
| June 30, 2017 | -6.252M |
| March 31, 2017 | 1.858M |
| December 31, 2016 | 6.304M |
| September 30, 2016 | -7.196M |
| June 30, 2016 | -3.513M |
| March 31, 2016 | -4.006M |
| September 30, 2015 | -4.819M |
| June 30, 2015 | -6.714M |
| March 31, 2015 | -3.743M |
| December 31, 2014 | -4.479M |
| September 30, 2014 | -4.307M |
| June 30, 2014 | -2.601M |
| March 31, 2014 | -1.58M |
| December 31, 2013 | -3.648M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Exlites Holdings International, Inc. | -0.0086M |
| Xcelerate, Inc. | -0.0542M |
| Vivos Therapeutics, Inc. | -5.523M |
| Hinge Health, Inc. | 43.10M |
| PD-Rx Pharmaceuticals, Inc. | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 9.131M |
| Total Expenses (Quarterly) | 8.865M |
| EPS Diluted (Quarterly) | 0.0057 |
| Enterprise Value | 37.90M |
| Gross Profit Margin (Quarterly) | 61.91% |
| Profit Margin (Quarterly) | 2.91% |
| Earnings Yield | 61.71% |
| Operating Earnings Yield | 10.52% |
| Normalized Earnings Yield | 61.50 |